Pharmacy

Your Article Summary

See Latest Articles

Polyvascular atherosclerotic disease: recognizing the risks and managing the syndrome
Current Medical Research and Opinion, 09/25/09

Yakubov S – According to limited data from patient registries, anywhere from 15% to 30% of patients with atherosclerosis present with disease in multiple vascular territories and experience significantly greater rates of adverse cardiovascular events. Although any conclusions are limited by this small number of studies, clinicians typically treat only the initially affected territory without consideration of the other affected territories and may lack awareness of the overall atherothrombotic syndrome.

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09

See All of Cardiac/Hypertension

Today in Pharmacy Management...keeping you current

Receive free subspecialty "5-minute updates" via email

Effect of a weight-based prescribing method within an electronic health record on prescribing errors
American Journal of Health-System Pharmacy, 11/10/09

A Practical Approach for Training Pharmacists and Pharmacy Students to Prevent Disease by Immunizations
Journal of Pharmacy Practice, 11/05/09

Uncomfortable prescribing decisions in hospitals: the impact of teamwork
Journal of the Royal Society of Medicine, 11/02/09

See All of Pharmacy Management